HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Endovascular treatment of critical leg ischemia of arteriosclerosis obliterans].

AbstractOBJECTIVE:
To evaluate the outcomes of percutaneous transluminal angioplasty (PTA) and stenting in the treatment of critical lower extremity ischemia of arteriosclerosis obliterans.
METHODS:
From April 2005 to May 2006, PTA and stenting was performed on 29 limbs of 24 patients with critical lower limb ischemia. Among all these patients, their main clinical symptom was rest pain, while ulceration and gangrene were also found in 12 patients. Four limbs underwent PTA, 4 limbs underwent prosthetic femoral-popliteal bypass with infrapopliteal balloon dilatation simultaneously, and the remaining 21 limbs were performed by PTA and stent placement.
RESULTS:
The success rate of endovascular procedure was 100% for femoral-popliteal artery, and 88% for infrapopliteal artery. Rest pain disappeared and the ulcers were healed after the operations. Only 1 patient received amputation during the operation.
CONCLUSION:
Endovascular therapy is an effective and safe procedure for the treatment of critical lower limb ischemia.
AuthorsChang-Wei Liu, Bao Liu, Wei Ye, Heng Guan, Yue-Hong Zheng, Yong-Jun Li, Rong Zeng, Leng Ni, Jiang Shao, Feng Tang
JournalZhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae (Zhongguo Yi Xue Ke Xue Yuan Xue Bao) Vol. 29 Issue 1 Pg. 33-6 (Feb 2007) ISSN: 1000-503X [Print] China
PMID17380662 (Publication Type: English Abstract, Journal Article)
Topics
  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon (methods)
  • Arteriosclerosis Obliterans (complications, therapy)
  • Female
  • Femoral Artery
  • Humans
  • Ischemia (etiology, therapy)
  • Leg (blood supply)
  • Male
  • Middle Aged
  • Popliteal Artery
  • Prosthesis Implantation
  • Retrospective Studies
  • Stents
  • Tibial Arteries
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: